Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
SLAS Discovery : Advancing Life Sciences R & D
|
March 20, 2022
Lead identification using 3D models of pancreatic cancer
Virneliz Fernandez-Vega, Shurong Hou, Dennis Plenker, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
August 22, 2024
High throughput screening for SARS-CoV-2 helicase inhibitors
Yuka Otsuka, Eunjung Kim, Austin Krueger, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
January 21, 2023
Protocol for 3D screening of lung cancer spheroids using natural products
Virneliz Fernández Vega, Dong Yang, Luis Ortiz Jordán, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
May 4, 2025
Hyperphosphorylated tau-based Alzheimer's Disease drug discovery: Identification of inhibitors of tau aggregation and cytotoxicity
Hsiao-Tien Hagar, Virneliz Fernandez-Vega, Kuang-Wei Wang, et al.
Journal of Medicinal Chemistry
|
January 22, 2024
Rebamipide and Derivatives are Potent, Selective Inhibitors of Histidine Phosphatase Activity of the Suppressor of T Cell Receptor Signaling Proteins
Faisal Aziz, Kanamata Reddy, Virneliz Fernandez Vega, et al.
Biorxiv : the Preprint Server for Biology
|
March 31, 2025
The <i>Endo-GeneScreen</i> Platform Identifies Drug-Like Probes that Regulate Endogenous Protein Levels within Physiological Contexts
Preston Samowitz, Laszlo Radnai, Thomas Vaissiere, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
August 1, 2020
Identification of Small-Molecule Inhibitors of Neutral Ceramidase (nCDase) via Target-Based High-Throughput Screening
Yuka Otsuka, Michael V Airola, Yong-Mi Choi, et al.
Nature Communications
|
December 9, 2025
The Endo-GeneScreen platform identifies drug-like probes that regulate endogenous protein levels within physiological contexts
Preston Samowitz, Laszlo Radnai, Thomas Vaissiere, et al.
Molecular Neuropsychiatry
|
March 30, 2018
Improved Scalability of Neuron-Based Phenotypic Screening Assays for Therapeutic Discovery in Neuropsychiatric Disorders
Timothy P Spicer, Christopher Hubbs, Thomas Vaissiere, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
August 22, 2024
SARS-CoV-2 M<sup>pro</sup> inhibitor identification using a cellular gain-of-signal assay for high-throughput screening
Renee Delgado, Jyoti Vishwakarma, Seyed Arad Moghadasi, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
SLAS Discovery : Advancing Life Sciences R & D
|
March 20, 2022
Lead identification using 3D models of pancreatic cancer
Virneliz Fernandez-Vega, Shurong Hou, Dennis Plenker, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
August 22, 2024
High throughput screening for SARS-CoV-2 helicase inhibitors
Yuka Otsuka, Eunjung Kim, Austin Krueger, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
January 21, 2023
Protocol for 3D screening of lung cancer spheroids using natural products
Virneliz Fernández Vega, Dong Yang, Luis Ortiz Jordán, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
May 4, 2025
Hyperphosphorylated tau-based Alzheimer's Disease drug discovery: Identification of inhibitors of tau aggregation and cytotoxicity
Hsiao-Tien Hagar, Virneliz Fernandez-Vega, Kuang-Wei Wang, et al.
Journal of Medicinal Chemistry
|
January 22, 2024
Rebamipide and Derivatives are Potent, Selective Inhibitors of Histidine Phosphatase Activity of the Suppressor of T Cell Receptor Signaling Proteins
Faisal Aziz, Kanamata Reddy, Virneliz Fernandez Vega, et al.
Biorxiv : the Preprint Server for Biology
|
March 31, 2025
The <i>Endo-GeneScreen</i> Platform Identifies Drug-Like Probes that Regulate Endogenous Protein Levels within Physiological Contexts
Preston Samowitz, Laszlo Radnai, Thomas Vaissiere, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
August 1, 2020
Identification of Small-Molecule Inhibitors of Neutral Ceramidase (nCDase) via Target-Based High-Throughput Screening
Yuka Otsuka, Michael V Airola, Yong-Mi Choi, et al.
Nature Communications
|
December 9, 2025
The Endo-GeneScreen platform identifies drug-like probes that regulate endogenous protein levels within physiological contexts
Preston Samowitz, Laszlo Radnai, Thomas Vaissiere, et al.
Molecular Neuropsychiatry
|
March 30, 2018
Improved Scalability of Neuron-Based Phenotypic Screening Assays for Therapeutic Discovery in Neuropsychiatric Disorders
Timothy P Spicer, Christopher Hubbs, Thomas Vaissiere, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
August 22, 2024
SARS-CoV-2 M<sup>pro</sup> inhibitor identification using a cellular gain-of-signal assay for high-throughput screening
Renee Delgado, Jyoti Vishwakarma, Seyed Arad Moghadasi, et al.
Page
of 4